Why This Biotech Stock Cratered 72% On Its Gene Therapy Study [Investor's Business Daily]
Sarepta Therapeutics, Inc. (SRPT)
Last sarepta therapeutics, inc. earnings: 2/26 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investorrelations.sarepta.com/events-and-presentations
Company Research
Source: Investors Business Daily
Related news 12/24/2018 Sarepta Therapeutics, Sage Therapeutics and Loxo Oncology are the most likely takeover candidates among biotech stocks in 2019, according to... Biotech Stock Reverses Course After 'Unwarranted' Decline On Early Data These Biopharmas Could Cure Genetic Diseases — At $5 Million Apiece Amid Broader Downturn, These 3 Biotech Stocks Look 'Compelling' These Biotechs Are Poised As 'Standouts' Heading Into Earnings Sarepta Jumps After FDA Removes Hold Barring Gene-Therapy Study Why Analysts Remain Bullish On This Biotech Despite Europe Rejection Dow's Pfizer Scraps A Pair Of Studies — Prodding These Rivals To Pop These Gene Therapy Stocks Are Spiking — Here's Why Solid Biosciences stock crashed Thursday after its experimental gene therapy disappointed in a study of Duchenne muscular dystrophy patients. In premarket trading on today's stock market , shares of Solid Biosciences ( SLDB ) tanked 72.7%, near 6.10. Solid Biosc
Show less
Read more
Impact Snapshot
Event Time:
SRPT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SRPT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SRPT alerts
High impacting Sarepta Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
SRPT
News
- How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings [Yahoo! Finance]Yahoo! Finance
- Bullish Sarepta Therapeutics Insiders Loaded Up On US$13.3m Of Stock [Yahoo! Finance]Yahoo! Finance
- Sarepta Therapeutics to Announce First Quarter 2024 Financial ResultsBusiness Wire
- GSK Gears Up for Q1 Earnings: Here's What to Expect [Yahoo! Finance]Yahoo! Finance
- IRA Capital Acquires 237,000 Square-Foot Life Science/R&D Campus in Columbus [Yahoo! Finance]Yahoo! Finance
SRPT
Earnings
- 2/28/24 - Beat
SRPT
Sec Filings
- 4/24/24 - Form DEF
- 4/24/24 - Form ARS
- 4/24/24 - Form DEFA14A
- SRPT's page on the SEC website